Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.837 USD | +0.84% | -40.21% | +20.95% |
05-14 | Stephens Starts Sensei Biotherapeutics With Overweight Rating, $5 Price Target | MT |
05-09 | Sensei Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.95% | 20.82M | |
+8.38% | 115B | |
+10.13% | 105B | |
-11.69% | 22.71B | |
+2.21% | 21.83B | |
-10.88% | 18.18B | |
-41.90% | 16.52B | |
-16.00% | 16.01B | |
+2.28% | 14.14B | |
+20.54% | 10.71B |
- Stock Market
- Equities
- SNSE Stock
- News Sensei Biotherapeutics, Inc.
- Oppenheimer Upgrades Sensei Biotherapeutics to Outperform From Perform; Price Target is $5